
The global Metformin Hydrochloride market size is predicted to grow from US$ 422 million in 2025 to US$ 587 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.
The global key manufacturers of Metformin Hydrochloride include Keyuan Pharmaceutical, Aarti Drugs and Shijiazhuang Polee, etc, top 3 manufacturers hold a share approximately 36%. Keyuan Pharmaceutical is the world's largest Metformin Hydrochloride manufacturer, with a market share of more than 14%. India, China and Europe are the major Metformin Hydrochloride market, they have a market share of more than 68%. India is the largest market with a share of 46%. In terms of product type, Metformin HCL is the largest market segment with a share of more than 82%. In terms of applications, Metformin Hydrochloride Tablets is the largest downstream segment, with a market share of about 72%.
The “Metformin Hydrochloride Industry Forecast” looks at past sales and reviews total world Metformin Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Metformin Hydrochloride sales for 2025 through 2031. With Metformin Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metformin Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Metformin Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metformin Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metformin Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metformin Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metformin Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Metformin Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Metformin HCL
Metformin DC
Segmentation by Application:
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Metformin Hydrochloride market?
What factors are driving Metformin Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metformin Hydrochloride market opportunities vary by end market size?
How does Metformin Hydrochloride break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metformin Hydrochloride Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Metformin Hydrochloride by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Metformin Hydrochloride by Country/Region, 2020, 2024 & 2031
2.2 Metformin Hydrochloride Segment by Type
2.2.1 Metformin HCL
2.2.2 Metformin DC
2.3 Metformin Hydrochloride Sales by Type
2.3.1 Global Metformin Hydrochloride Sales Market Share by Type (2020-2025)
2.3.2 Global Metformin Hydrochloride Revenue and Market Share by Type (2020-2025)
2.3.3 Global Metformin Hydrochloride Sale Price by Type (2020-2025)
2.4 Metformin Hydrochloride Segment by Application
2.4.1 Metformin Hydrochloride Tablets
2.4.2 Metformin Hydrochloride Extended-Release Tablets
2.4.3 Others
2.5 Metformin Hydrochloride Sales by Application
2.5.1 Global Metformin Hydrochloride Sale Market Share by Application (2020-2025)
2.5.2 Global Metformin Hydrochloride Revenue and Market Share by Application (2020-2025)
2.5.3 Global Metformin Hydrochloride Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Metformin Hydrochloride Breakdown Data by Company
3.1.1 Global Metformin Hydrochloride Annual Sales by Company (2020-2025)
3.1.2 Global Metformin Hydrochloride Sales Market Share by Company (2020-2025)
3.2 Global Metformin Hydrochloride Annual Revenue by Company (2020-2025)
3.2.1 Global Metformin Hydrochloride Revenue by Company (2020-2025)
3.2.2 Global Metformin Hydrochloride Revenue Market Share by Company (2020-2025)
3.3 Global Metformin Hydrochloride Sale Price by Company
3.4 Key Manufacturers Metformin Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metformin Hydrochloride Product Location Distribution
3.4.2 Players Metformin Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Metformin Hydrochloride by Geographic Region
4.1 World Historic Metformin Hydrochloride Market Size by Geographic Region (2020-2025)
4.1.1 Global Metformin Hydrochloride Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Metformin Hydrochloride Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Metformin Hydrochloride Market Size by Country/Region (2020-2025)
4.2.1 Global Metformin Hydrochloride Annual Sales by Country/Region (2020-2025)
4.2.2 Global Metformin Hydrochloride Annual Revenue by Country/Region (2020-2025)
4.3 Americas Metformin Hydrochloride Sales Growth
4.4 APAC Metformin Hydrochloride Sales Growth
4.5 Europe Metformin Hydrochloride Sales Growth
4.6 Middle East & Africa Metformin Hydrochloride Sales Growth
5 Americas
5.1 Americas Metformin Hydrochloride Sales by Country
5.1.1 Americas Metformin Hydrochloride Sales by Country (2020-2025)
5.1.2 Americas Metformin Hydrochloride Revenue by Country (2020-2025)
5.2 Americas Metformin Hydrochloride Sales by Type (2020-2025)
5.3 Americas Metformin Hydrochloride Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metformin Hydrochloride Sales by Region
6.1.1 APAC Metformin Hydrochloride Sales by Region (2020-2025)
6.1.2 APAC Metformin Hydrochloride Revenue by Region (2020-2025)
6.2 APAC Metformin Hydrochloride Sales by Type (2020-2025)
6.3 APAC Metformin Hydrochloride Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Metformin Hydrochloride by Country
7.1.1 Europe Metformin Hydrochloride Sales by Country (2020-2025)
7.1.2 Europe Metformin Hydrochloride Revenue by Country (2020-2025)
7.2 Europe Metformin Hydrochloride Sales by Type (2020-2025)
7.3 Europe Metformin Hydrochloride Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metformin Hydrochloride by Country
8.1.1 Middle East & Africa Metformin Hydrochloride Sales by Country (2020-2025)
8.1.2 Middle East & Africa Metformin Hydrochloride Revenue by Country (2020-2025)
8.2 Middle East & Africa Metformin Hydrochloride Sales by Type (2020-2025)
8.3 Middle East & Africa Metformin Hydrochloride Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metformin Hydrochloride
10.3 Manufacturing Process Analysis of Metformin Hydrochloride
10.4 Industry Chain Structure of Metformin Hydrochloride
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metformin Hydrochloride Distributors
11.3 Metformin Hydrochloride Customer
12 World Forecast Review for Metformin Hydrochloride by Geographic Region
12.1 Global Metformin Hydrochloride Market Size Forecast by Region
12.1.1 Global Metformin Hydrochloride Forecast by Region (2026-2031)
12.1.2 Global Metformin Hydrochloride Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Metformin Hydrochloride Forecast by Type (2026-2031)
12.7 Global Metformin Hydrochloride Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Wanbury
13.1.1 Wanbury Company Information
13.1.2 Wanbury Metformin Hydrochloride Product Portfolios and Specifications
13.1.3 Wanbury Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Wanbury Main Business Overview
13.1.5 Wanbury Latest Developments
13.2 USV
13.2.1 USV Company Information
13.2.2 USV Metformin Hydrochloride Product Portfolios and Specifications
13.2.3 USV Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 USV Main Business Overview
13.2.5 USV Latest Developments
13.3 Shouguang Fukang Pharmaceutical
13.3.1 Shouguang Fukang Pharmaceutical Company Information
13.3.2 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Portfolios and Specifications
13.3.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shouguang Fukang Pharmaceutical Main Business Overview
13.3.5 Shouguang Fukang Pharmaceutical Latest Developments
13.4 Vistin Pharma
13.4.1 Vistin Pharma Company Information
13.4.2 Vistin Pharma Metformin Hydrochloride Product Portfolios and Specifications
13.4.3 Vistin Pharma Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Vistin Pharma Main Business Overview
13.4.5 Vistin Pharma Latest Developments
13.5 CR Double-Crane
13.5.1 CR Double-Crane Company Information
13.5.2 CR Double-Crane Metformin Hydrochloride Product Portfolios and Specifications
13.5.3 CR Double-Crane Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CR Double-Crane Main Business Overview
13.5.5 CR Double-Crane Latest Developments
13.6 Keyuan Pharmaceutical
13.6.1 Keyuan Pharmaceutical Company Information
13.6.2 Keyuan Pharmaceutical Metformin Hydrochloride Product Portfolios and Specifications
13.6.3 Keyuan Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Keyuan Pharmaceutical Main Business Overview
13.6.5 Keyuan Pharmaceutical Latest Developments
13.7 Farmhispania Group
13.7.1 Farmhispania Group Company Information
13.7.2 Farmhispania Group Metformin Hydrochloride Product Portfolios and Specifications
13.7.3 Farmhispania Group Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Farmhispania Group Main Business Overview
13.7.5 Farmhispania Group Latest Developments
13.8 Harman Finochem
13.8.1 Harman Finochem Company Information
13.8.2 Harman Finochem Metformin Hydrochloride Product Portfolios and Specifications
13.8.3 Harman Finochem Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Harman Finochem Main Business Overview
13.8.5 Harman Finochem Latest Developments
13.9 Shijiazhuang Polee Pharmaceutical
13.9.1 Shijiazhuang Polee Pharmaceutical Company Information
13.9.2 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Portfolios and Specifications
13.9.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shijiazhuang Polee Pharmaceutical Main Business Overview
13.9.5 Shijiazhuang Polee Pharmaceutical Latest Developments
13.10 Aarti Drugs
13.10.1 Aarti Drugs Company Information
13.10.2 Aarti Drugs Metformin Hydrochloride Product Portfolios and Specifications
13.10.3 Aarti Drugs Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Aarti Drugs Main Business Overview
13.10.5 Aarti Drugs Latest Developments
13.11 Exemed Pharmaceuticals
13.11.1 Exemed Pharmaceuticals Company Information
13.11.2 Exemed Pharmaceuticals Metformin Hydrochloride Product Portfolios and Specifications
13.11.3 Exemed Pharmaceuticals Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Exemed Pharmaceuticals Main Business Overview
13.11.5 Exemed Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
*If Applicable.
